Highbridge Capital Management’s Avanos Medical AVNS Stock Holding History

Highbridge Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,894	Closed	-$339K	–	1235
2017 Q1	$339K	Buy	+8,894	New	+$347K	﹤0.01%	1088
2016 Q4	–	Sell	-109,899	Closed	-$3.81M	–	1246
2016 Q3	$3.81M	Buy	+109,899	New	+$3.85M	0.06%	317
2015 Q4	–	Sell	-255,341	Closed	-$7.94M	–	1491
2015 Q3	$7.26M	Buy	255,341 +72,326	+40%	+$2.52M	0.11%	230
2015 Q2	$7.41M	Buy	183,015 +147,478	+415%	+$6.62M	0.09%	232
2015 Q1	$1.75M	Buy	+35,537	New	+$1.65M	0.02%	570

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Highbridge Capital Management's AVNS Position: Q2 2017 in Review

Highbridge Capital Management sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 8,894 shares — an estimated $339K sold.

Highbridge Capital Management first reported a position in AVNS in Q1 2015 and held it in 5 quarters. The position peaked at $7.41M in Q2 2015. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

Highbridge Capital Management reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
Highbridge Capital Management sold 8,894 Avanos Medical shares in Q2 2017, an estimated $339K.
Highbridge Capital Management first reported a position in Avanos Medical in Q1 2015 and held it in 5 quarters.
Highbridge Capital Management's Avanos Medical position peaked at $7.41M in Q2 2015.
328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.